Neurogene Inc. (NGNE)

Last Closing Price: 27.74 (2026-04-20)

EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Neurogene Inc. (NGNE) EBITDA Margin data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-24.73M
--
--
$27.53M
$-27.53M
$2.79M
$-24.73M
$-24.73M
$-24.73M
$-24.73M
$-24.73M
$-24.73M
$-27.53M
$-27.24M
21.33M
21.33M
$-1.12
$-1.12
Balance Sheet Financials
$271.77M
$12.79M
$16.83M
$288.60M
$16.41M
$0.01M
$7.31M
$23.72M
$264.89M
$264.89M
$264.89M
15.49M
Cash Flow Statement Financials
$-77.17M
$14.00M
$30.43M
$136.93M
$104.18M
$-32.74M
$14.18M
--
--
Fundamental Metrics & Ratios
16.56
--
--
0.00
0.00
--
--
--
EBITDA Margin
--
--
--
$-78.36M
--
--
--
--
--
--
--
-9.34%
-9.34%
-8.57%
-9.34%
$17.10
$-3.67
$-3.62